Tango Therapeutics, Inc. · NASDAQ:TNGX
TCG Crossover GP II, L.P. reported a 9.99% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
TCG Crossover GP II, L.P. reported a 9.99% stake in Tango Therapeutics, Inc., 13,521,839 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 13,521,839
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, L.P. | 9.99% | 13,521,839 |
| TCG Crossover Fund II, L.P. | 9.99% | 13,521,839 |
| Chen Yu | 9.99% | 13,521,839 |
Source
Related
- Tango Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 14, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026
- Schedule 13G/A · Nextech Crossover I GP S.a. r.l. · Aug 14, 2026